ANTX AN2 Therapeutics, Inc. - Common Stock
$4,53
Fiyat · May 20, 2026
Temel veriler itibarıyla May 11, 2026
52 Haftlık Aralık
$1–$7
60% of range
Analist Derecelendirmesi
HOLD
6 analysts
Fiyat Hedefi
$9
+99% upside
P/E (TTM)
-1.0
ROE
-57.7%
Net Kâr Marjı
—
ANTX Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$4.53
Piyasa Değeri
$31M
P/E (TTM)
-1.0
EPS (TTM)
$-1.16
Gelir (TTM)
—
Temettü Verimi
—
ROE
-57.7%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$1 – $7
ANTX Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
—
Hisse Başına Kâr
$-1.16
2021-12-31
→
2025-12-31
Serbest Nakit Akışı
—
Marjlar
—
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
ANTX
Akran Ortalaması
P/E (TTM)
-1.0
42.1
P/B (F/D)
0.6
6.6
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
ANTX
Akran Ortalaması
ROA
-45.7%
-45.7%
ROE
-57.7%
-46.4%
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
ANTX
Akran Ortalaması
Current Ratio (Cari Oran)
6.9
1.6
Quick Ratio (Cari Oran)
2.3
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
ANTX
Akran Ortalaması
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
ANTX
Akran Ortalaması
ANTX Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
SAT
6 analist
- Güçlü Al 0 0,0%
- Al 0 0,0%
- Tut 3 50,0%
- Sat 1 16,7%
- Güçlü Sat 2 33,3%
12 Aylık Fiyat Hedefi
1 analist · 2026-05-16
Düşük
$9.00
Yüksek
$9.00
Medyan hedef
$9.00
+98,7%
Ortalama hedef
$9.00
+98,7%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-0.02%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2026 | $-0.29 | $-0.23 | -0.06% |
| 31 Aralık 2025 | $-0.29 | $-0.24 | -0.05% |
| 30 Eylül 2025 | $-0.31 | $-0.22 | -0.09% |
| 30 Haziran 2025 | $-0.21 | $-0.34 | 0.13% |
| 31 Mart 2025 | $-0.35 | $-0.26 | -0.09% |
| 31 Aralık 2024 | $-0.25 | $-0.26 | 0.01% |
Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| ANTX | $31M | -1.0 | — | — | -57.7% | — |
| LENZ | $502M | -5.6 | — | -430.2% | -33.5% | — |
| CNTX | $135M | -3.9 | 112.7% | — | -50.5% | — |
| ORMP | $112M | 1.9 | -50.4% | 3202.5% | 37.0% | 0.65% |
| DERM | — | -16.4 | 10.2% | -18.5% | -44.7% | — |
| ASRT | $58M | -1.9 | -5.0% | -25.6% | -32.4% | — |
| PLYX | — | — | — | — | -193.7% | — |
| NTHI | — | -2.6 | -51.8% | — | — | — |
| TTRX | $116M | -32.8 | — | — | -141.7% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 13
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| R&D Expense | $25M | $40M | $55M | $29M | $16M | |
| SG&A Expense | $13M | $14M | $15M | $13M | $5M | |
| Operating Expenses | $38M | $57M | $70M | $42M | $22M | |
| Operating Income | $-38M | $-57M | $-70M | $-42M | $-22M | |
| Interest Income | $3M | $5M | $5M | · | · | |
| Other Non-op | $1.0K | $1.0K | $43.0K | $1M | $-38.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-35M | $-51M | $-65M | $-41M | $-22M | |
| EPS (Basic) | $-1.16 | $-1.72 | $-2.74 | $-2.79 | $-10.64 | |
| EPS (Diluted) | $-1.16 | $-1.72 | $-2.74 | $-2.79 | $-10.64 | |
| Shares (Basic) | 30,215,747 | 29,828,227 | 23,600,107 | 15,340,134 | 2,638,197 | |
| Shares (Diluted) | 30,215,747 | 29,828,227 | 23,600,107 | 15,340,134 | 2,638,197 | |
| EBITDA | $-38M | $-57M | · | $-42M | · |
Bilanço 16
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $20M | $21M | $16M | $27M | $12M | |
| Prepaid Expense | $2M | $3M | $3M | $3M | $2M | |
| Current Assets | $60M | $86M | $111M | $99M | $60M | |
| Other Non-current Assets | $0 | $804.0K | $1M | $720.0K | · | |
| Total Assets | $62M | $92M | $139M | $103M | $65M | |
| Accounts Payable | $3M | $3M | $3M | $2M | $1M | |
| Accrued Liabilities | $2M | $4M | $7M | $3M | $1M | |
| Current Liabilities | $9M | $10M | $14M | $7M | $3M | |
| Other Non-current Liabilities | $170.0K | $0 | · | · | · | |
| Total Liabilities | $9M | $10M | $14M | $7M | $3M | |
| Paid-in Capital | $294M | $288M | $279M | $185M | · | |
| Retained Earnings | $-241M | $-206M | $-154M | $-90M | $-47M | |
| AOCI | $57.0K | $31.0K | $275.0K | $-374.0K | $-27.0K | |
| Stockholders' Equity | $53M | $82M | $125M | $95M | $-47M | |
| Liabilities + Equity | $62M | $92M | $139M | $103M | $65M | |
| Shares Outstanding | 27,413,171 | 29,919,634 | 29,741,445 | 19,402,658 | 2,730,298 |
Nakit Akışı 9
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $8M | $8M | $4M | $974.0K | |
| Restructuring | · | $2M | · | · | · | |
| Operating Cash Flow | $-30M | $-49M | $-53M | $-33M | $-20M | |
| Investing Cash Flow | $28M | $55M | $-43M | $-22M | $-50M | |
| Stock Issued | $86.0K | $147.0K | $366.0K | · | · | |
| Net Stock Activity | $86.0K | $147.0K | · | · | · | |
| Financing Cash Flow | $113.0K | $372.0K | $85M | $70M | $79M | |
| Net Change in Cash | $-1M | $6M | $-12M | $15M | $8M | |
| Taxes Paid | $0 | $0 | · | · | · |
Kârlılık 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| ROA | -45.7% | -44.5% | · | -48.8% | · | |
| ROE | -57.7% | -60.6% | · | -40.8% | · |
Likidite ve Solventlik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 6.9 | · | · | 13.7 | · | |
| Quick Ratio | 2.3 | · | · | 3.8 | · |
Değerleme (TTM) 7
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-35M | $-51M | $-65M | $-41M | · | |
| Market Cap | $31M | $41M | · | $185M | · | |
| P/E | -1.0 | -0.8 | -7.5 | -3.4 | · | |
| P/B | 0.6 | 0.5 | · | 1.9 | · | |
| P / Tangible Book | 0.6 | 0.5 | 4.9 | 1.9 | · | |
| P / Cash Flow | -1.0 | -0.8 | · | -5.5 | · | |
| Earnings Yield | -101.8% | -124.6% | -13.4% | -29.3% | · |
Gelir Tablosu 12
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $7M | $7M | $7M | $3M | $8M | $5M | $8M | $12M | $15M | $15M | $14M | $14M | $12M | $9M | $7M | $7M | |
| SG&A Expense | $4M | $2M | $3M | $4M | $4M | $3M | $3M | $4M | $4M | $4M | $4M | $3M | $4M | $4M | $3M | $4M | |
| Operating Expenses | $11M | $9M | $10M | $7M | $12M | $9M | $14M | $16M | $18M | $19M | $18M | $17M | $16M | $12M | $12M | $10M | |
| Operating Income | $-11M | $-9M | $-10M | $-7M | $-12M | $-9M | $-14M | $-16M | $-18M | $-19M | $-18M | $-17M | $-16M | $-12M | $-12M | $-10M | |
| Interest Income | $523.0K | $605.0K | $687.0K | $754.0K | $888.0K | $1M | $1M | $1M | $2M | · | · | · | · | · | · | · | |
| Other Non-op | · | · | · | · | · | $-1M | $1M | $0 | $1.0K | $-3M | $1M | $797.0K | $716.0K | $634.0K | $431.0K | $213.0K | |
| Net Income | $-10M | $-9M | $-9M | $-6M | $-11M | $-8M | $-13M | $-14M | $-17M | $-17M | $-17M | $-16M | $-15M | $-12M | $-11M | $-10M | |
| EPS (Basic) | $-0.29 | $-0.29 | $-0.31 | $-0.21 | $-0.35 | $-0.25 | $-0.43 | $-0.48 | $-0.56 | $-0.49 | $-0.65 | $-0.81 | $-0.79 | $1.31 | $-0.59 | $-0.53 | |
| EPS (Diluted) | $-0.29 | $-0.29 | $-0.31 | $-0.21 | $-0.35 | $-0.25 | $-0.43 | $-0.48 | $-0.56 | $-0.49 | $-0.65 | $-0.81 | $-0.79 | $1.31 | $-0.59 | $-0.53 | |
| Shares (Basic) | 34,059,876 | -60,286,470 | 30,276,230 | 30,172,328 | 30,053,659 | -59,600,945 | 29,841,169 | 29,824,725 | 29,763,278 | -40,928,454 | 25,645,421 | 19,497,494 | 19,385,646 | -26,445,797 | 19,347,148 | 19,258,066 | |
| Shares (Diluted) | 34,059,876 | -60,286,470 | 30,276,230 | 30,172,328 | 30,053,659 | -59,600,945 | 29,841,169 | 29,824,725 | 29,763,278 | -40,928,454 | 25,645,421 | 19,497,494 | 19,385,646 | -26,445,797 | 19,347,148 | 19,258,066 | |
| EBITDA | $-11M | · | $-10M | $-7M | $-12M | · | $-14M | $-16M | $-18M | · | $-18M | $-17M | $-16M | · | $-12M | $-10M |
Bilanço 16
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $53M | $20M | $18M | $18M | $20M | $21M | $34M | $27M | $25M | $16M | $33M | $41M | $27M | $27M | $29M | $41M | |
| Prepaid Expense | $2M | $2M | $2M | $5M | $2M | $3M | $4M | $3M | $2M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | |
| Current Assets | $87M | $60M | $64M | $68M | $70M | $86M | $98M | $107M | $116M | $111M | $126M | $98M | $90M | $99M | $107M | $117M | |
| Other Non-current Assets | · | $0 | $0 | $0 | $304.0K | $804.0K | · | $1M | $1M | $1M | $1M | $720.0K | $720.0K | $720.0K | $720.0K | $720.0K | |
| Total Assets | $87M | $62M | $67M | $76M | $81M | $92M | $98M | $108M | $121M | $139M | $154M | $99M | $91M | $103M | $110M | $120M | |
| Accounts Payable | $3M | $3M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $3M | $5M | $3M | $4M | $2M | $1M | $2M | |
| Accrued Liabilities | $2M | $2M | $3M | $3M | $4M | $4M | $5M | $6M | $7M | $7M | $7M | $6M | $4M | $3M | $2M | $2M | |
| Current Liabilities | $6M | $9M | · | · | · | $10M | $10M | · | · | · | $15M | $11M | $9M | $7M | $4M | $4M | |
| Other Non-current Liabilities | $170.0K | $170.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $6M | $9M | $7M | $7M | $8M | $10M | $10M | $10M | $11M | $14M | $15M | $11M | $9M | $7M | $4M | $4M | |
| Paid-in Capital | $333M | $294M | $293M | $292M | $290M | $288M | $286M | $284M | $282M | $279M | $277M | $209M | $188M | $185M | $184M | $183M | |
| Retained Earnings | $-251M | $-241M | $-232M | $-223M | $-216M | $-206M | $-198M | $-186M | $-171M | $-154M | $-138M | $-121M | $-105M | $-90M | $-78M | $-67M | |
| AOCI | $-5.0K | $57.0K | $64.0K | $25.0K | $48.0K | $31.0K | $112.0K | $-27.0K | $53.0K | $275.0K | $-122.0K | $-119.0K | $-175.0K | $-374.0K | $-541.0K | $-360.0K | |
| Stockholders' Equity | $82M | $53M | $60M | $69M | $73M | $82M | $88M | $98M | $111M | $125M | $139M | $88M | $83M | $95M | $106M | $116M | |
| Liabilities + Equity | $87M | $62M | $67M | $76M | $81M | $92M | $98M | $108M | $121M | $139M | $154M | $99M | $91M | $103M | $110M | $120M | |
| Shares Outstanding | 35,985,599 | 27,413,171 | 27,371,154 | 27,376,461 | 30,141,517 | 29,919,634 | 29,868,583 | 29,829,040 | 29,815,663 | 29,741,445 | 29,741,445 | 21,928,452 | 19,426,452 | 19,402,658 | 19,402,658 | 19,402,658 |
Nakit Akışı 8
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $1M | $801.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | |
| Restructuring | · | · | · | · | · | $-9.0K | $2M | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-12M | $-5M | $-6M | $-8M | $-11M | $-5M | $-12M | $-14M | $-18M | $-17M | $-12M | $-13M | $-12M | $-8M | $-9M | $-10M | |
| Investing Cash Flow | $8M | $7M | $6M | $6M | $9M | $-7M | $19M | $16M | $26M | $420.0K | $-62M | $8M | $11M | $6M | $-2M | $-39M | |
| Stock Issued | · | $0 | $48.0K | $0 | $38.0K | $0 | $23.0K | $0 | $124.0K | $0 | $167.0K | $0 | $199.0K | · | · | · | |
| Net Stock Activity | · | · | · | · | $38.0K | · | · | · | $124.0K | · | · | · | $199.0K | · | · | · | |
| Financing Cash Flow | $37M | $0 | $48.0K | $0 | $65.0K | $0 | $23.0K | $0 | $349.0K | $-321.0K | $66M | $19M | $199.0K | $0 | $-10.0K | $7M | |
| Net Change in Cash | $34M | $2M | $-217.0K | $-2M | $-1M | $-12M | $7M | $2M | $9M | $-17M | $-8M | $14M | $-510.0K | $-2M | $-12M | $-42M |
Kârlılık 2
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -11.9% | · | -11.3% | -7.0% | -10.5% | · | -10.1% | -13.9% | -15.7% | · | -12.7% | -14.4% | -14.5% | · | -20.6% | -16.9% | |
| ROE | -12.9% | · | -12.6% | -7.7% | -11.6% | · | -11.2% | -15.5% | -17.2% | · | -13.7% | -15.5% | -15.5% | · | -21.5% | -17.5% |
Likidite ve Solventlik 2
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 15.7 | · | · | · | · | · | 9.8 | · | · | · | 8.5 | 8.8 | 10.5 | · | 24.2 | 28.2 | |
| Quick Ratio | 9.6 | · | · | · | · | · | 3.3 | · | · | · | 2.2 | 3.7 | 3.1 | · | 6.5 | 9.8 |
Değerleme (TTM) 7
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-36M | · | $-39M | $-44M | $-54M | · | $-61M | $-64M | $-64M | · | $-59M | $-53M | $-44M | · | $-36M | $-30M | |
| Market Cap | $123M | · | $35M | $29M | $41M | · | $32M | $64M | $97M | · | $478M | $186M | $192M | · | $337M | $150M | |
| P/E | -2.9 | · | -1.0 | -0.7 | -0.7 | · | -0.5 | -0.9 | -1.2 | · | -5.7 | -3.1 | -2.0 | · | -2.3 | -0.8 | |
| P/B | 1.5 | · | 0.6 | 0.4 | 0.6 | · | 0.4 | 0.7 | 0.9 | · | 3.4 | 2.1 | 2.3 | · | 3.2 | 1.3 | |
| P / Tangible Book | 1.5 | · | 0.6 | 0.4 | 0.6 | · | 0.4 | 0.7 | 0.9 | · | 3.4 | 2.1 | 2.3 | · | 3.2 | 1.3 | |
| P / Cash Flow | -10.2 | · | · | · | -3.9 | · | · | · | -5.5 | · | · | · | -16.5 | · | · | · | |
| Earnings Yield | -33.9% | · | -102.4% | -138.7% | -133.8% | · | -198.1% | -116.3% | -86.5% | · | -17.7% | -32.0% | -49.5% | · | -42.9% | -122.3% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Net Gelir | $-35M | $-51M | $-65M | $-41M | $-22M |
| Seyreltilmiş Hisse Başı Kâr | $-1.16 | $-1.72 | $-2.74 | $-2.79 | $-10.64 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Cari Oran | 6.9 | — | — | 13.7 | — |
| Cari Oran | 2.3 | — | — | 3.8 | — |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.